A potent and orally active HIV-1 integrase inhibitor
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1392-1398
- https://doi.org/10.1016/j.bmcl.2006.11.080
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Practical Synthesis of 4‐Fluoro‐2‐(methylthio)benzylamine and the Corresponding Sulfone and SulfonamideSynthetic Communications, 2007
- Integrase inhibitors to treat HIV/AidsNature Reviews Drug Discovery, 2005
- A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integraseProceedings of the National Academy of Sciences, 2004
- Structure and Function of HIV-1 IntegraseCurrent Topics in Medicinal Chemistry, 2004
- HIV-1 integrase: a target for new AIDS chemotherapeutics.Current Topics in Medicinal Chemistry, 2004
- Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected CellsJournal of Medicinal Chemistry, 2003
- 4-Aryl-2,4-dioxobutanoic Acid Inhibitors of HIV-1 Integrase and Viral Replication in CellsJournal of Medicinal Chemistry, 2000
- Surveying for Surfaces that Resist the Adsorption of ProteinsJournal of the American Chemical Society, 2000
- L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.Proceedings of the National Academy of Sciences, 1994